Bakkenolides from Petasites tatewakianus

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Organic Chemistry

Background:

• Petasites species are known sources of bioactive sesquiterpenoids called bakkenolides.
• Investigating the chemical constituents of Petasites tatewakianus can lead to the discovery of novel compounds with potential therapeutic applications.

Purpose of the Study:

• To isolate and characterize chemical constituents from Petasites tatewakianus.
• To evaluate the in vitro cytotoxic activity of the isolated compounds against various cancer cell lines.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation of the new bakkenolide using spectroscopic methods (IR, EIMS, HRESIMS, 1D and 2D NMR).
• Structure confirmation of the known compound via single crystal X-ray structural analysis.
• In vitro cytotoxicity assays against HeLa, MCF-7, and LLC cell lines.

Main Results:

• A new bakkenolide, along with a known bakkenolide, was successfully isolated from Petasites tatewakianus.
• The structure of the new bakkenolide was determined through comprehensive spectroscopic analysis.
• The known compound's structure was confirmed by X-ray crystallography.
• Both isolated bakkenolides exhibited in vitro cytotoxic activity against tested cancer cell lines.

Conclusions:

• Petasites tatewakianus is a source of structurally diverse bakkenolides.
• The isolated bakkenolides possess cytotoxic properties, warranting further investigation for anticancer drug development.